Literature 2007, Drug development (KMG045)

(Läkemedelsutveckling)

The literature list is not final but will be updated.

The articles are available as downloadable pde files except in a few cases where
instead a direct link to the journal is provided. 

Martin Billeter 

Stockman & Dalvit, Progr. NMR Spectroscopy 41:187-231 (2002)

(except pp. 198 - 220)

Gunnar Bjursell

Anders Blomberg

Pandey & Mann, Nature 405:837-846 (2000)

Lars Brive

Sven Erickson

Imai & Takaoka, Nature Reviews Cancer 6:714-727 (2006)

Weinstein & Joe, Nature Clinical Practice Oncology 3:448 (2006)

Morten Grötli

Dancey & Sausville, Nature Reviews Drug Discovery 2:296-313 (2003)

Ola Hammarsten

Fanyi Jiang

Sundberg, Curr. Op. Biotechnol. 11:47 - 53 (2000)

Thomsen et al., Curr. Op. Biotechnol. 16:655 – 665 (2005)

Yan et al., J. Biomolecular Screening 7:451 – 459 (2002)

Aheme et al., Breast Cancer Res. 4:148 – 154 (2002)

Göran Karlsson

Tomas Lundqvist

Lundqvist et al., Nature 447:817 - 822 (2007)

Björn Löwenadler

Numann & Negulescu,  Trends Cardiovasc. Med. 11:54-59 (2001)

Meltzer,  Curr. Opin. Genet. Dev. 11:258 – 263 (2001)

Chiesi et al., Trends Pharmacol. Sci. 22:247-254 (2001)

Terstappen & Reggiani Trends Pharmacol. Sci. 22:23-26 (2001)

Margit Mahlapuu 

Schmidt-Supprian & Rajewsky  Nature Immunol. 8:665-668 (2007)

Lewandoski M.  Nature Rev. Genet. 2:743-755 (2001)

Thomas Olsson

Reed et al, Nature Rev. Drug Discovery 3:660 - 672 (2004)

Marc Pilon

Jones et al., Nature Rev. Drug Discovery 4:321-330 (2005)

Per Sunnerhagen

Armour & Lum, Curr. Op. Chem. Biol. 9:20-24 (2005)

Parsons et al., Cell 126:611-625 (2006)